Tag #Aortic Stenosis

Showing 1 to 3 of 3 results

kathimerini.gr

🌐 65% Global Worthiness

Sep 2, 13:20

Aortic Valve Stenosis: One Patient's Journey and Recovery

Dr. Howard LeWine, Harvard Health Publishing's medical editor, shares his experience with aortic valve stenosis, its diagnosis, management, and eventual surgical replacement, highlighting the importance of regular monitoring and proactive treatment.

Aortic Valve Stenosis: One Patient's Journey and Recovery

Dr. Howard LeWine, Harvard Health Publishing's medical editor, shares his experience with aortic valve stenosis, its diagnosis, management, and eventual surgical replacement, highlighting the importance of regular monitoring and proactive treatment.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key diagnostic steps and monitoring procedures for aortic valve stenosis, as illustrated by Dr. LeWine's case?

Dr. LeWine's stenosis was initially detected via a routine heart exam revealing a characteristic murmur. Subsequent echocardiograms tracked disease progression, showing moderate stenosis initially, later necessitating stress echocardiograms and more frequent monitoring due to the detection of an ascending aortic aneurysm. A CCTA scan was performed pre-surgery to assess coronary arteries and confirmed a bicuspid valve.

elmundo.es

🌐 85% Global Worthiness

Mar 29, 22:12

Dapagliflozin Improves Outcomes in Post-TAVI Aortic Stenosis Patients

A clinical trial involving 1,250 patients with severe aortic stenosis demonstrated that dapagliflozin, an SGLT-2 inhibitor, significantly reduced mortality and hospital readmissions for heart failure following transcatheter aortic valve implantation (TAVI), prompting calls for updated clinical guide...

Dapagliflozin Improves Outcomes in Post-TAVI Aortic Stenosis Patients

A clinical trial involving 1,250 patients with severe aortic stenosis demonstrated that dapagliflozin, an SGLT-2 inhibitor, significantly reduced mortality and hospital readmissions for heart failure following transcatheter aortic valve implantation (TAVI), prompting calls for updated clinical guide...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does this study address the limitations of previous research on SGLT-2 inhibitors and heart failure in elderly patients?

The DapaTAVI trial highlights the potential for dapagliflozin to improve the prognosis of patients with aortic stenosis after TAVI, a less invasive procedure for older patients. The study's success underscores the need to revise clinical guidelines to include SGLT-2 inhibitors as a standard post-TAVI treatment for high-risk patients. This is crucial given that up to 20% of post-TAVI patients experience heart failure or death within the first year.

theguardian.com

🌐 85% Global Worthiness

Jun 5, 04:10

Aortic Stenosis Treatment Disparities in England

A University of Leicester study analyzing almost 155,000 aortic stenosis cases (2000-2022) found women were 11% less likely for secondary care and 39% less likely for valve replacement than men; patients in deprived areas had 7% lower referral and 4% lower procedure rates; black patients 48% less li...

Aortic Stenosis Treatment Disparities in England

A University of Leicester study analyzing almost 155,000 aortic stenosis cases (2000-2022) found women were 11% less likely for secondary care and 39% less likely for valve replacement than men; patients in deprived areas had 7% lower referral and 4% lower procedure rates; black patients 48% less li...

Progress

24% Bias Score

ShareSaveArticle

No Poverty

12345678

Previous 1 of 8 Next

What factors might contribute to the observed disparities in access to aortic stenosis treatment across different demographic and socioeconomic groups?

These disparities highlight inequities in accessing aortic stenosis treatment, impacting women, minority ethnic groups (Black patients 48% less likely, South Asian 27% less likely for valve replacement), and those in deprived areas. The study, using anonymized GP records from 2000-2022, suggests potential systemic barriers to care.

Showing 1 to 3 of 3 results